Obesity pill comparison: How Novo, Lilly and others stack upnews2025-08-07T15:41:03+00:00August 7th, 2025|Endpoints News|
Merck’s infant RSV antibody gets CDC’s recommendationnews2025-08-07T13:13:15+00:00August 7th, 2025|Endpoints News|
FDA removes hold on Valneva’s chikungunya vaccine in those over 60, adjusts product labelnews2025-08-07T11:20:07+00:00August 7th, 2025|Endpoints News|
Lilly’s rise in revenue clouded by Phase 3 obesity pill readoutnews2025-08-07T11:11:05+00:00August 7th, 2025|Endpoints News|
Endpoints livestream: What we learned from Q2 earnings about China, tariffs and Trumpnews2025-08-07T11:00:53+00:00August 7th, 2025|Endpoints News|
Merck KGaA joins other drugmakers in considering direct-to-patient US sales news2025-08-07T10:52:40+00:00August 7th, 2025|Endpoints News|
Elevidys sales fall again in Sarepta’s second quarter amid safety issuesnews2025-08-07T00:55:35+00:00August 7th, 2025|Endpoints News|
Sixth Circuit judges uphold IRA decision in government’s favornews2025-08-06T20:56:32+00:00August 6th, 2025|Endpoints News|
FDA approves targeted brain cancer drug from Jazz’s Chimerix buyout news2025-08-06T19:43:30+00:00August 6th, 2025|Endpoints News|
Novo Nordisk, Sanofi, Lilly to face renewed fight over alleged 340B price fixingnews2025-08-06T19:31:28+00:00August 6th, 2025|Endpoints News|
